TSXV - Delayed Quote CAD

NurExone Biologic Inc. (NRX.V)

Compare
0.6700 -0.0100 (-1.47%)
At close: November 5 at 3:59 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
?

Analyst Price Targets

4.03
4.03 Average
0.6700 Current
4.03 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts --111
Avg. Estimate 0-0.04-0.17-0.18
Low Estimate 0-0.04-0.17-0.18
High Estimate 0-0.04-0.17-0.18
Year Ago EPS -0.03-0.03-0.11-0.17

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1111
Avg. Estimate --------
Low Estimate --------
High Estimate --------
Year Ago Sales --------
Sales Growth (year/est) --------

Earnings History

CURRENCY IN USD 6/30/2023 9/30/2023 12/31/2023 3/31/2024
EPS Est. -0.03-0.03-0.03-0.03
EPS Actual -0.03-0.03-0.02-0.03
Difference 000.010
Surprise % 0.00%0.00%33.30%0.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 0-0.04-0.17-0.18
7 Days Ago -0.03-0.04-0.17-0.18
30 Days Ago -0.03-0.03-0.11-0.11
60 Days Ago -0.03-0.03-0.11-0.11
90 Days Ago -0.03-0.03-0.11-0.11

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD NRX.VIndustrySectorS&P 500
Current Qtr. ------5.40%
Next Qtr. -33.30%----11.80%
Current Year -54.50%----2.20%
Next Year -5.90%----12.50%
Next 5 Years (per annum) ------11.03%
Past 5 Years (per annum) --------

Related Tickers